{
  "docId": "019de06f-57cf-712e-a58f-75e608a89acf",
  "docSlug": "72cbc476cbb3df5012eb344c4961ce5a",
  "documentTitle": "Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Valeant",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2014-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.5571777,
  "pageNumber": 37,
  "pageCount": 40,
  "prevPage": 36,
  "nextPage": 38,
  "slideType": "initiative_list",
  "function": "recommend",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Includes a background watermark of a tree, likely symbolizing growth or integration.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de06f-57cf-712e-a58f-75e608a89acf/37",
  "deckHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf",
  "deckJsonHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf.json",
  "deckAnchorHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf#slide-37",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.73,
        "y": 0.93
      },
      "kind": "image",
      "text": "VALEANT Pharmaceuticals International, Inc.",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1519c5a9-8011-4445-b974-c0d4375f4f8f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.06,
        "y": 0.19
      },
      "kind": "list",
      "text": "Maintain majority of Allergan aesthetics team; keep relationships in place between the company and physicians\n- Injectables, Breast Aesthetics, Devices: Plan to maintain field force, no overlapping sales team\n- Obagi and Skinmedica: Expectation to maintain separate sales teams given unique product offerings\nKeep late stage R&D programs and high potential early stage programs\nEmphasize commercial efforts on growing the market with a focus on the physician practice\n- Help recruit new patients to physician offices\n- Develop physician loyalty programs to support physician empowerment\n- Expand opportunities and new products for your practice (e.g., eye whitening, aesthetic contact lenses)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23841d4b-cc86-4959-8e27-2d0001ec6d2e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Initial thoughts for Allergan Aesthetics integration",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16f1466c-ae9f-4b4c-bad8-a27c406eee5e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 33,
      "beatId": "cd21e60c-5f8c-4e21-b4ee-841538c314d4",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Integration plans, initiative lists, and future collaboration objectives",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}